TY - JOUR
T1 - The Neuroimmune Pharmacology of SARS-CoV-2
AU - Kumar, Santosh
AU - Yelamanchili, Sowmya
AU - Seth, Pankaj
AU - Bidlack, Jean M.
AU - Pendyala, Gurudutt
AU - Maggirwar, Sanjay
AU - Chang, Sulie L.
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/12
Y1 - 2021/12
N2 - This guest commentary introduces “The Neuroimmune Pharmacology of SARS-CoV-2,” a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society’s Virtual Workshop on COVID-19 held April 9, 2021. Graphical abstract: Top row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.[Figure not available: see fulltext.].
AB - This guest commentary introduces “The Neuroimmune Pharmacology of SARS-CoV-2,” a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society’s Virtual Workshop on COVID-19 held April 9, 2021. Graphical abstract: Top row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.[Figure not available: see fulltext.].
KW - COVID-19
KW - Diversity
KW - Early-career investigators
KW - Equity and inclusion
KW - Neuroimmune pharmacology
KW - Oral history
KW - SARS-CoV-2
KW - Therapeutics
KW - Vaccines
KW - Well-being
UR - http://www.scopus.com/inward/record.url?scp=85121477438&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121477438&partnerID=8YFLogxK
U2 - 10.1007/s11481-021-10038-z
DO - 10.1007/s11481-021-10038-z
M3 - Comment/debate
C2 - 34935110
AN - SCOPUS:85121477438
SN - 1557-1890
VL - 16
SP - 699
EP - 705
JO - Journal of Neuroimmune Pharmacology
JF - Journal of Neuroimmune Pharmacology
IS - 4
ER -